Skip to content
MBQ Pharma logo — Cancer will not spread throughout the body.

MBQ Pharma

Cancer will not spread throughout the body.

Founded 2018 Puerto Rico Puerto Rico 4 employees Biopharma, Biotechnology +2

General Information

Company Name MBQ Pharma
Founded Year 2018
Location Puerto Rico Puerto Rico
Employees 4
Industries Biopharma, Biotechnology, Health Care +1
Social

BounceWatch is an independent company data service, not affiliated with MBQ Pharma. To contact MBQ Pharma, visit mbqpharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does MBQ Pharma compare?

A PDF of MBQ Pharma and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting MBQ Pharma soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About MBQ Pharma

MBQ Pharma is a biopharmaceutical company based in Puerto Rico, founded in 2018. The company's focus is on developing innovative solutions to combat cancer, with the slogan "Cancer will not spread throughout the body." Their flagship product, MBQ-167, is a first-in-class nanomolar IC50 inhibitor for Rac and CDC42, targeting tumor growth inhibition and removal of pre-existing metastasis. The promising results in mouse tumor models, showing the inhibition of tumor growth and reversal of advanced metastasis, have garnered attention. Notably, the product has exhibited no toxicity findings in rats and dogs through GLP studies and in Safety Pharmacology studies, positioning it as a potentially safe and effective solution. With the IND for MBQ-167 scheduled by the end of 2021, MBQ Pharma presents an intriguing opportunity for investment in the biopharma, biotechnology, health care, and pharmaceutical industries. However, as of now, no specific information about recent investments or investors is available.

Business keywords: Cancer treatment, Tumor growth inhibition, Metastasis prevention, Rac inhibitor, CDC42 inhibitor, MBQ-167, First-in-class inhibitor, Mouse tumor models, Toxicity studies, IND submission, Oncology, Therapeutics, GLP studies, Safety pharmacology, Drug development

No funding data available for MBQ Pharma yet.

MBQ Pharma Alternatives & Competitors

View All Alternatives
MBQ Pharma vs
OncoSpherix
OncoSpherix United States

Advanced drugs for advanced cancers

Grant
5 employees
Health Care, Pharmaceutical
MBQ Pharma vs

Sunesis is a biopharmaceutical company focused on the development and future commercialization of ne...

Post-IPO Equity
42 employees
Biotechnology, Health Care
MBQ Pharma vs

Outsmart Cancer

Seed
10 employees
Biotechnology, Health Care

FAQ About MBQ Pharma

Cancer will not spread throughout the body.
MBQ Pharma was founded in 2018.
MBQ Pharma is headquartered in Puerto Rico.
MBQ Pharma operates in Biopharma, Biotechnology, Health Care and Pharmaceutical. Its work centres on Cancer treatment, Tumor growth inhibition, Metastasis prevention and Rac inhibitor.
MBQ Pharma has approximately 4 employees.
Top alternatives and competitors to MBQ Pharma include OncoSpherix, Sunesis Pharmaceuticals, Inc., TRIO Pharmaceuticals, Inc., BioReperia, Macomics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MBQ Pharma and OncoSpherix are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for MBQ Pharma, https://bouncewatch.com/company/mbq-pharma, updated 28 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout